Gamlen Tableting Extends Global Reach
Gamlen Tableting Limited has appointed Nihon Validation Technologies Corporation as the exclusive distributor of the Gamlen Tablet Press in Japan to further extend the global reach of the business.
Nihon Validation Technologies is a leading supplier of pharmaceutical laboratory equipment, specialising in dissolution testing products, and an experienced provider of validation and qualification services.
Offering the GTP-1 bench top computer controlled tablet press and its many associated accessories will enable Nihon Validation Technologies to substantially extend its product range.
The flexibility of the GTP-1 combined with its sophistication and its many applications in preformulation, formulation and process development, and Production, makes it particularly attractive in the Japanese market.
Dr Michael Gamlen, Managing Director, Gamlen Tableting commented: “The GTP-1 has attracted a truly global customer base. With increasing interest in the GTP-1 originating from Japan, the time was right for Gamlen Tableting to expand into this market. We are delighted to be working with Nihon Validation Technologies as the company has a proven history of providing high quality equipment and testing solutions.”
Atsushi Tanabe, Chief Executive Officer of the Nihon Validation Technology Corporation, said “We are looking forward to working with Gamlen Tableting Ltd to promote their excellent new product, which we believe has many potential sales in Japan. It builds on the excellent history of innovation within our own organisation”.
Nihon Validation Technologies has a staff of over 18 people with clients throughout the Japanese pharmaceutical industry.
Related News
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance